Whales with a lot of money to spend have taken a noticeably bullish stance on Abbott Laboratories.
Looking at options history for Abbott Laboratories ABT we detected 9 trades.
If we consider the specifics of each trade, it is accurate to state that 33% of the investors opened trades with bullish expectations and 33% with bearish.
From the overall spotted trades, 3 are puts, for a total amount of $280,109 and 6, calls, for a total amount of $391,570.
Predicted Price Range
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $90.0 to $130.0 for Abbott Laboratories over the last 3 months.
Analyzing Volume & Open Interest
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Abbott Laboratories's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Abbott Laboratories's substantial trades, within a strike price spectrum from $90.0 to $130.0 over the preceding 30 days.
Abbott Laboratories 30-Day Option Volume & Interest Snapshot
Biggest Options Spotted:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ABT | PUT | TRADE | BULLISH | 01/16/26 | $4.7 | $4.3 | $4.4 | $90.00 | $132.0K | 255 | 0 |
| ABT | CALL | SWEEP | BEARISH | 06/20/25 | $18.75 | $17.25 | $17.25 | $95.00 | $115.5K | 5 | 33 |
| ABT | PUT | TRADE | NEUTRAL | 08/16/24 | $20.05 | $19.55 | $19.83 | $125.00 | $105.0K | 3 | 0 |
| ABT | CALL | TRADE | BULLISH | 08/16/24 | $7.75 | $7.7 | $7.75 | $100.00 | $77.5K | 214 | 0 |
| ABT | CALL | SWEEP | BEARISH | 08/16/24 | $7.75 | $7.65 | $7.65 | $100.00 | $57.3K | 214 | 250 |
About Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Following our analysis of the options activities associated with Abbott Laboratories, we pivot to a closer look at the company's own performance.
Abbott Laboratories's Current Market Status
- With a trading volume of 6,857,104, the price of ABT is down by -0.14%, reaching $104.52.
- Current RSI values indicate that the stock is may be approaching oversold.
- Next earnings report is scheduled for 69 days from now.
Expert Opinions on Abbott Laboratories
A total of 2 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $132.5.
- Maintaining their stance, an analyst from RBC Capital continues to hold a Outperform rating for Abbott Laboratories, targeting a price of $125.
- An analyst from Barclays has decided to maintain their Overweight rating on Abbott Laboratories, which currently sits at a price target of $140.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Abbott Laboratories with Benzinga Pro for real-time alerts.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date of Trade | ticker | Put/Call | Strike Price | DTE | Sentiment |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
